flomoxef has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aramaki, O; Isaji, S; Itamoto, T; Kanematsu, T; Kubo, S; Kusunoki, M; Mochizuki, H; Oka, M; Shibata, T; Shimada, M; Sumiyama, Y; Takayama, T | 1 |
| Asakuma, M; Hayashi, M; Hirokawa, F; Inoue, Y; Komeda, K; Miyamoto, Y; Nishimura, Y; Shimizu, T; Uchiyama, K | 1 |
2 trial(s) available for flomoxef and Liver Neoplasms
| Article | Year |
|---|---|
Antimicrobial prophylaxis for 1 day versus 3 days in liver cancer surgery: a randomized controlled non-inferiority trial.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Carcinoma, Hepatocellular; Cephalosporins; Female; Hepatectomy; Humans; Japan; Liver Neoplasms; Male; Middle Aged; Surgical Wound Infection; Time Factors | 2019 |
Evaluation of postoperative antibiotic prophylaxis after liver resection: a randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biomarkers; Carcinoma, Hepatocellular; Cephalosporins; Cholangiocarcinoma; Female; Hepatectomy; Humans; Infections; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Surgical Wound Infection; Systemic Inflammatory Response Syndrome; Treatment Failure | 2013 |